Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.99

€1.99

6.420%
0.12
6.420%
-

-

 
14.04.26 / Frankfurt WKN: A414VY / Name: Tvardi Therapeutics Inc. / Stock / ? /
Latest predictions
13.10.25
-61.51%
Best running prediction
-
13.10.25
-61.51%
Your prediction

Tvardi Therapeutics Inc. Stock

A very strong showing by Tvardi Therapeutics Inc. today, with an increase of €0.12 (6.420%) compared to yesterday's price.
Our community identified positive and negative aspects for Tvardi Therapeutics Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tvardi Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Tvardi Therapeutics Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi


Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc.. (“Tvardi” or the “Company”) (NASDAQ: TVRD).



Faruqi & Faruqi is a